Filetti S, Rapoport B
Endocrinology. 1983 Nov;113(5):1608-15. doi: 10.1210/endo-113-5-1608.
Studies were conducted to define more clearly the site in the thyroid adenylate cyclase complex at which iodine exerts its inhibitory effect on activation of this enzyme by TSH. Iodine- and TSH-induced desensitization were additive. Dissociation was observed between the rates of recovery from TSH- and iodine-induced desensitization. Cycloheximide (10(-4) M) prevented recovery from the inhibitory effect of iodine on thyroid adenylate cyclase activation. Preincubation of freshly isolated dog thyroid follicles in 10(-4) M iodide decreased the subsequent cAMP response to cholera toxin (0.5 micrograms/ml) stimulation. This effect of iodide was prevented by 3 mM methimazole. Thyroid adenylate cyclase regulatory protein (Ns) activity was assessed by the ability of detergent extracts of thyroid plasma membranes to reconstitute adenylate cyclase responsiveness to isoproterenol in N-deficient S49 cyc- plasma membranes. Thyroid Ns activities were similar in control and iodide-pretreated thyroid cells. The inhibitory effect of iodine on TSH activation of thyroid cAMP generation was additive to that of inhibition via the alpha 2- adrenergic pathway and also additive to inhibition by 2',5'-dideoxyadenosine (an adenosine P-site agonist). Preincubation of freshly dispersed dog thyroid cells in 10(-4) M NaI reduced the cAMP response to stimulation by 100 microM forskolin. These data provide evidence that in iodine-induced TSH desensitization in the thyroid; 1) TSH receptor function is normal, 2) the regulatory protein (Ns) in the adenylate cyclase stimulatory pathway is functionally unaltered, 3) iodine does not exert its effect via the regulatory protein (Ni) in the pathway that inhibits adenylate cyclase activation, 4) iodine does not act via the adenosine P-site inhibitory pathway, 5) the action of iodine is at or near the adenylate cyclase catalytic unit, and 6) new protein synthesis is necessary for recovery from iodine desensitization.
开展了多项研究,以更清楚地确定甲状腺腺苷酸环化酶复合物中碘对促甲状腺激素(TSH)激活该酶发挥抑制作用的位点。碘诱导的脱敏和TSH诱导的脱敏具有累加性。观察到从TSH诱导的脱敏和碘诱导的脱敏中恢复的速率之间存在解离。放线菌酮(10⁻⁴M)可阻止甲状腺腺苷酸环化酶激活受碘抑制作用后的恢复。将新鲜分离的犬甲状腺滤泡在10⁻⁴M碘化物中预孵育,会降低随后对霍乱毒素(0.5微克/毫升)刺激的环磷酸腺苷(cAMP)反应。3 mM甲巯咪唑可阻止碘化物的这种作用。通过甲状腺质膜的去污剂提取物在缺乏N的S49 cyc⁻质膜中重建腺苷酸环化酶对异丙肾上腺素反应性的能力,来评估甲状腺腺苷酸环化酶调节蛋白(Ns)的活性。对照甲状腺细胞和经碘化物预处理的甲状腺细胞中的甲状腺Ns活性相似。碘对甲状腺cAMP生成的TSH激活的抑制作用,与通过α₂ - 肾上腺素能途径的抑制作用具有累加性,并且与2',5'-二脱氧腺苷(一种腺苷P位点激动剂)的抑制作用也具有累加性。将新鲜分散的犬甲状腺细胞在10⁻⁴M碘化钠中预孵育,会降低对100微摩尔毛喉素刺激的cAMP反应。这些数据提供了证据,表明在甲状腺中碘诱导的TSH脱敏过程中:1)TSH受体功能正常;2)腺苷酸环化酶刺激途径中的调节蛋白(Ns)功能未改变;3)碘并非通过抑制腺苷酸环化酶激活途径中的调节蛋白(Ni)发挥作用;4)碘并非通过腺苷P位点抑制途径起作用;5)碘的作用发生在腺苷酸环化酶催化单位处或其附近;6)从碘脱敏中恢复需要新的蛋白质合成。